Raymond James Financial Services Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-134,983
| Closed | -$120K | – | 3388 |
|
|
2022
Q4 | $120K | Sell |
134,983
-9,500
| -7% | -$8.42K | ﹤0.01% | 2979 |
|
|
2022
Q3 | $227K | Buy |
144,483
+250
| +0.2% | +$393 | ﹤0.01% | 2760 |
|
|
2022
Q2 | $290K | Sell |
144,233
-16,962
| -11% | -$34.1K | ﹤0.01% | 2612 |
|
|
2022
Q1 | $376K | Buy |
161,195
+12,264
| +8% | +$28.6K | ﹤0.01% | 2545 |
|
|
2021
Q4 | $693K | Sell |
148,931
-66,230
| -31% | -$308K | ﹤0.01% | 2179 |
|
|
2021
Q3 | $1.64M | Buy |
215,161
+24,907
| +13% | +$190K | ﹤0.01% | 1615 |
|
|
2021
Q2 | $1.84M | Buy |
190,254
+10,918
| +6% | +$106K | ﹤0.01% | 1519 |
|
|
2021
Q1 | $1.48M | Buy |
179,336
+34,814
| +24% | +$288K | ﹤0.01% | 1580 |
|
|
2020
Q4 | $986K | Sell |
144,522
-93,006
| -39% | -$635K | ﹤0.01% | 1714 |
|
|
2020
Q3 | $2.65M | Buy |
237,528
+180,005
| +313% | +$2.01M | 0.01% | 1038 |
|
|
2020
Q2 | $361K | Buy |
57,523
+44,946
| +357% | +$282K | ﹤0.01% | 2127 |
|
|
2020
Q1 | $23K | Buy |
12,577
+2,050
| +19% | +$3.75K | ﹤0.01% | 2345 |
|
|
2019
Q4 | $36K | Sell |
10,527
-1,932
| -16% | -$6.61K | ﹤0.01% | 2765 |
|
|
2019
Q3 | $27K | Hold |
12,459
| – | – | ﹤0.01% | 2718 |
|
|
2019
Q2 | $33K | Hold |
12,459
| – | – | ﹤0.01% | 2749 |
|
|
2019
Q1 | $59K | Buy |
+12,459
| New | +$59K | ﹤0.01% | 2684 |
|